News


07/29/15, Company Bayer significantly improves earnings Very good business development at HealthCare / CropScience performance steady in a weaker market environment / MaterialScience posts robust earnings growth / Group sales increase to EUR 12,090 million (plus 18.2 percent / Fx & portfolio adj. plus 3.7 percent) / EBITDA before special items improves by 33.2 percent to EUR 2,899 million / EBIT advances by 27.7 percent to EUR 1,833 million / Net income increases 20.9 percent to EUR 1,152 million / Core earnings per share up 33.8 percent to EUR 1.98 / Group forecast 2015 for operational performance of continuing operations confirmed and adjusted for currency effects more

#YourPerfectMatch

A major consumer awareness campaign by Bayer HealthCare kicked off on Valentine’s Day 2015 drawing attention to the highly reliable, but little known Long Acting Contraceptives (LAC) more

Working Together to Combat River Blindness

Agreement between Bayer and the DNDi on the development of a new drug

more

How important to the world is the right to sexual and reproductive self-determination?

This year's International Dialogue on Population and Sustainable Development at the beginning of November was held against a special backdrop. The deadline for the Millennium Sustainable Development Goals which the United Nations had set at the turn of the millennium expires in 2015...

more

Bayer Clinical Trials

Information about Bayer sponsored clinical studies is available at

Facebook

Facebook Banner

Follow us on Facebook

more

Links


http://pharma.bayer.com/en/index.php?n=irp

Copyright © Bayer Pharma AG